Albutein should be administered with caution to patients with low cardiac reserve.
Rapid infusion may cause vascular overload with resultant pulmonary edema. Patients should be closely monitored for signs of increased venous pressure.
A rapid rise in blood pressure following infusion necessitates careful observation of injured or postoperative patients to detect and treat severed blood vessels that may not have bled at a lower pressure.
Patients with marked dehydration require administration of additional fluids. Albutein may be administered with the usual dextrose and saline intravenous solutions. However, solutions containing protein hydrolysates or alcohol must not be infused through the same administration set in conjunction with Albutein since these combinations may cause the proteins to precipitate.
Use in Pregnancy: Pregnancy Category C: Animal reproduction studies have not been conducted with Albutein. It is also not known whether Albutein can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Albutein should be given to a pregnant woman only if clearly needed.